Equillium (EQ) EBIAT (2022 - 2025)
Equillium (EQ) has disclosed EBIAT for 4 consecutive years, with -$4.2 million as the latest value for Q3 2025.
- On a quarterly basis, EBIAT fell 60328.57% to -$4.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$24.4 million, a 429.08% decrease, with the full-year FY2024 number at -$8.1 million, up 39.51% from a year prior.
- EBIAT was -$4.2 million for Q3 2025 at Equillium, up from -$5.7 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of $2.8 million in Q4 2022 to a low of -$37.4 million in Q1 2022.
- A 4-year average of -$6.8 million and a median of -$3.9 million in 2023 define the central range for EBIAT.
- Peak YoY movement for EBIAT: skyrocketed 114.0% in 2024, then crashed 60328.57% in 2025.
- Equillium's EBIAT stood at $2.8 million in 2022, then tumbled by 184.46% to -$2.3 million in 2023, then plummeted by 147.4% to -$5.8 million in 2024, then grew by 26.99% to -$4.2 million in 2025.
- Per Business Quant, the three most recent readings for EQ's EBIAT are -$4.2 million (Q3 2025), -$5.7 million (Q2 2025), and -$8.7 million (Q1 2025).